Aquis Exchange accepts £194m offer from Swiss group in blow to London November 11, 2024 The offer values Aquis shares at 727p per share, a 120 per cent premium to Friday's closing price of 330p per share.
Barclays: Scrap stamp duty to drive UK capital markets boom September 16, 2024 Barclays has backed a review of stamp duty on share purchases in a bid to “revive” the UK’s flagging stock market. In a report on Monday, the bank argued that a variety of changes were needed to make London “internationally attractive”, as well as encouraging unlisted companies to float on the UK’s main market. The [...]
Aquis: Challenger London stock market reports ‘meaningful progress’ September 12, 2024 Aquis Exchange has reported increased revenue across the majority of its divisions in the first half of 2024 as the fledgling London bourse battles a "challenging market backdrop".
Aquis Exchange boss says UK poised for ‘tidal wave’ of foreign investment under Labour August 12, 2024 The chief executive of challenger stock exchange Aquis has said the UK is in store for a "tidal wave of international investment" following Labour's election victory.
Starmer and Reeves told to put capital markets at heart of economic strategy July 11, 2024 The chief executives of challenger stock exchange Aquis and retail investment platform PrimaryBid have urged the new government to prioritise opening up UK markets to new capital as an engine for economic growth.
Debts, disputes and a ‘shadow CEO’: The curious case of Truspine June 18, 2024 Truspine Technologies has failed to take off since it floated nearly four years ago - and some are arguing this failure merits further investigation by City regulators. City A.M. takes a closer look at the firm’s labyrinthine history, uncovering a myriad of debts, disputes and detractors
Exclusive: Why this London-based AI firm has picked Aquis for its float next month June 12, 2024 Pri0r1ty AI automates tasks like writing press releases, regulatory news, and social media content, typically handled by multiple external agencies.
Truspine chief resigns ‘with immediate effect’ amid investor efforts to oust him May 7, 2024 The chief executive of a London-listed medical technology firm has resigned following investor efforts to oust him and the chief financial officer from the company.
Investors in London-listed medical tech firm continue battle to oust top brass April 24, 2024 Investors in a London-listed medical technology firm are continuing their campaign to oust the company’s top brass as its share price languishes.
Aquis: Profit jumps 15 per cent for fledgling London exchange March 21, 2024 Exchange Aquis has reported 15 per cent growth in profit before tax despite challenging market conditions last year, with all arms of the business bringing in new revenue. In the company’s full-year results for 2023, it reported net revenue of £22.7m, up 13 per cent from the year before. Profit before tax came in at [...]